A 1-year pilot study of vagus nerve stimulation in treatment-resistant rapid-cycling bipolar disorder

Journal of Clinical Psychiatry

Volumn 69, Issue 2, 2008, Pages 183-189

  Marangell, Lauren B ^a,d   Suppes, Trisha ^b   Zboyan, Holly A ^a   Prashad, Sandhya J ^a   Fischer, Grace ^b   Snow, Diane ^b   Sureddi, Suresh ^b   Allen Jr , John C ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Cyberonics Inc   (Italy)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CITALOPRAM; CLOZAPINE; GABAPENTIN; LAMOTRIGINE; LEVOTHYROXINE; LEVOTHYROXINE SODIUM; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; MONOAMINE OXIDASE INHIBITOR; OLANZAPINE; PSYCHOSTIMULANT AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TIROSINT; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID;

30 ITEM INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY SELF-REPORT; ADULT; AGED; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DEVICE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HAMILTON SCALE; HOARSENESS; HUMAN; MAJOR DEPRESSION; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTPATIENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAPID CYCLING BIPOLAR DISORDER; RATING SCALE; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; VAGUS NERVE STIMULATION; YOUNG MANIA RATING SCALE;

EID: 41549116887     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0203     Document Type: Article

References (30)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000
2. Schneck CD, Miklowitz DJ, Calabrese JR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry 2004;161:1902-1908
3. Calabrese JR, Rapport DJ, Youngstrom EA, et al. New data on the use of lithium, divalproate, and lamotrigine in rapid cycling bipolar disorder. Eur Psychiatry 2005;20:92-95
4. Rush AJ, Marangell LB, Sackeim HA, et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005;58:347-354
5. Leverich GS, Post RM. The NIMH Life Chart Manual for Recurrent Affective Illness: The LCM™-S/R Retrospective. Bethesda, Md: NIMH Monograph; 1997
6. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, et al. First International Vagus Nerve Stimulation Study Group. Vagus nerve stimulation for treatment of partial seizures, 1: a controlled study of effect on seizures. Epilepsia 1994;35:616-626
7. Vagus Nerve Stimulation Study Group. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 1995;45:224-230
8. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48-55
9. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY: Biometrics Research, New York State Psychiatric Institute; 2002
10. Denicoff KD, Smith-Jackson EE, Disney ER, et al. Preliminary evidence of the reliability and validity of the Prospective Life-Chart Methodology (LCM-p). J Psychiatr Res 1997;31:593-603
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
12. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296
13. Moberg PJ, Lazarus LW, Mesholam RI, et al. Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 2001;9:35-40
14. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389
15. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS) psychometric properties. Psychol Med 1996;26:477-486
16. Rush AJ, Carmody TJ, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): clinician (IDS-C) and self-report (IDS-SR) ratings of depressive symptoms. Int J Methods Psychiatr Res 2000;9:45-59
17. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34:73-82
18. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435
19. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
20. Quitkin FM. Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 1999;156:829-836
21. Nahas Z, Marangell LB, Husain MM, et al. Two-year outcome of vagus nerve stimulation (VNS) for major depressive episodes. J Clin Psychiatry 2005;66:1097-1104
22. Marangell LB, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002;51:280-287
23. Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry 1998;155:12-21
24. Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000;61:9-15
25. Levine J, Chengappa KN, Brar JS, et al. Psychotropic drug prescription patterns among patients with bipolar I disorder. Bipolar Disord 2000;2:120-130
26. Nichol MB, Stimmel GL, Lange SC. Factors predicting the use of multiple psychotropic medications. J Clin Psychiatry 1995;56:60-66
27. Calabrese JR, Shelton MD, Rapport DJ, et al. A 20-month double-blind, maintenance trial of lithium vs divalproex in rapid-cycling bipolar disorder. Am J Psychiatry 2005;162:2152-2161
28. Calabrese JR, Suppes T, Bowden CL, et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. J Clin Psychiatry 2000;61:841-850
29. Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder, pt 2: treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry 1990;47:435-440
30. Baumgartner A, Bauer M, Hellweg R. Treatment of intractable non-rapid cycling bipolar affective disorder with high-dose thyroxine: an open clinical trial. Neuropsychopharmacology 1994;10:183-189